The gut microbiome can influence the development of DM by modulating inflammation, insulin resistance, and the production of metabolites such as short-chain fatty acids (SCFAs), which play a role in regulating glucose metabolism and insulin sensitivity [8]. This evidence concerns the gene INS and Insulin resistance.